The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment decision patterns post–enfortumab vedotin plus pembrolizumab in metastatic urothelial cancer.
 
Paloma Galera
No Relationships to Disclose
 
Brian Russell
Travel, Accommodations, Expenses - EMD Serono
 
Ilana Epstein
No Relationships to Disclose
 
Stephanie Berg
Honoraria - Aptitude Health; Curio Science
Consulting or Advisory Role - Eisai; Exelixis; Guardant Health; Natera; Pfizer; Zencor
 
Charlene Mantia
Consulting or Advisory Role - AADi; Cogent Biosciences; EMD Serono; Nextech; Synthekine
Research Funding - Bristol-Myers Squibb (Inst)
 
Mitra Shavakhi
No Relationships to Disclose
 
Aya Abdelnaser
No Relationships to Disclose
 
Bradley McGregor
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; AVEO; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; Exelixis; Genmab; Gilead Sciences; Hexagon; Loxo/Lilly; Pfizer; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
 
Arvind Ravi
Stock and Other Ownership Interests - Halo Pharma
Consulting or Advisory Role - Halo Pharma; IBM (Inst); Tegus
 
Bicky Thapa
No Relationships to Disclose
 
Joaquim Bellmunt
Stock and Other Ownership Interests - Rainier Therapeutics
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono/Merck; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Pfizer/EMD Serono (Inst); Pfizer/Gilead
Patents, Royalties, Other Intellectual Property - UpToDate Bladder Cancer
Travel, Accommodations, Expenses - Genentech/Roche; Ipsen